GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Umedic Group Bhd (XKLS:0256) » Definitions » Intrinsic Value: Projected FCF

Umedic Group Bhd (XKLS:0256) Intrinsic Value: Projected FCF : RM0.00 (As of May. 31, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Umedic Group Bhd Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-05-31), Umedic Group Bhd's Intrinsic Value: Projected FCF is RM0.00. The stock price of Umedic Group Bhd is RM0.415. Therefore, Umedic Group Bhd's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Umedic Group Bhd's Intrinsic Value: Projected FCF or its related term are showing as below:

XKLS:0256's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.52
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Umedic Group Bhd Intrinsic Value: Projected FCF Historical Data

The historical data trend for Umedic Group Bhd's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Umedic Group Bhd Intrinsic Value: Projected FCF Chart

Umedic Group Bhd Annual Data
Trend Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Umedic Group Bhd Quarterly Data
Jul19 Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Umedic Group Bhd's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Umedic Group Bhd's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Umedic Group Bhd's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Umedic Group Bhd's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Umedic Group Bhd's Price-to-Projected-FCF falls into.


;
;

Umedic Group Bhd Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Umedic Group Bhd  (XKLS:0256) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Umedic Group Bhd's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.415/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Umedic Group Bhd Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Umedic Group Bhd's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Umedic Group Bhd Business Description

Traded in Other Exchanges
N/A
Address
PMT 790, Jalan Cassia Selatan 5/2, Taman Perindustrian Batu Kawan, Pulau Pinang, Bandar Cassia, PNG, MYS, 14110
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically.

Umedic Group Bhd Headlines

No Headlines